(Reuters) - Indian shares posted their fourth consecutive weekly gain on Friday, as Infosys Ltd and Tata Consultancy Services Ltd marked fresh record peaks, while pharmaceutical stocks such as Dr. Reddy's Laboratories Ltd rallied on the back of U.S. regulatory approvals.
The broader NSE index ended 0.09 percent higher at 10,817.70, gaining 0.46 percent for the week.
The benchmark BSE index closed up 0.06 percent at 35,622.14 and posted a weekly gain of 0.50 percent.
Infosys ended 3.4 percent higher, while Tata Consultancy Services Ltd closed up 2.9 percent after announcing a buyback of shares worth up to 160 billion rupees ($2.35 billion).
Dr. Reddy's Labs ended 3.5 percent higher.
(Reporting by Jessica Kuruthukulangara in Bengaluru, Editing by Sherry Jacob-Phillips)
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app